A Targeted Screening Program for Latent Tuberculosis Infection Among Hematopoietic Cell Transplant Recipients.

Andrea Sosa-MorenoMasahiro NaritaChristopher SpittersMichelle SwetkySara PodczervinskiMargaret L LindLeona HolmbergCatherine LiuRaleigh EdelsteinMirta Maravilla Rosas

Published in: Open forum infectious diseases (2020)

Incorporating a pretransplant LTBI questionnaire allowed for an approximate 65% reduction in LTBI testing when compared with universal testing among this low prevalence population.

Keyphrases

mycobacterium tuberculosis
single cell
risk factors
bone marrow
cell therapy
cross sectional
hiv aids
emergency department
mesenchymal stem cells
drug delivery
hepatitis c virus
human immunodeficiency virus
antiretroviral therapy
hiv infected